Page last updated: 2024-11-08

aspartic acid and HIV Infections

aspartic acid has been researched along with HIV Infections in 55 studies

Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.

HIV Infections: Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).

Research Excerpts

ExcerptRelevanceReference
"5 Tesla magnetic resonance scanner in HIV-infected subjects as follows: 12 subjects before (group 1) and after intensification of antiretroviral therapy with maraviroc (group 2) and 13 subjects with acute viral hepatitis C (HCV) co-infection (group 3)."3.81Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts. ( Garvey, L; Rojas, JH; Taylor-Robinson, S; Vigneswaran, S; Winston, A, 2015)
"The enhanced liver fibrosis (ELF) index is a highly sensitive noninvasive marker of hepatic fibrosis that has had limited assessment in the HIV/HCV population."1.62The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients. ( Abdel-Hameed, EA; Kottilil, S; Rouster, SD; Sherman, KE, 2021)
"The prevalence of hepatotoxicity, liver fibrosis, and CKD were 7."1.51Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana. ( Anabire, NG; Annan, I; Aryee, PA; Eliason, S; Hagan, OCK; Helegbe, GK; Luuse, AT; Obiri-Yaboah, D; Tetteh, WJ, 2019)

Research

Studies (55)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (12.73)18.2507
2000's19 (34.55)29.6817
2010's22 (40.00)24.3611
2020's7 (12.73)2.80

Authors

AuthorsStudies
Morgello, S2
Buyukturkoglu, K1
Murray, J1
Veenstra, M1
Berman, JW1
Byrd, D1
Inglese, M1
Zhen, L1
Qingyan, Z1
Bowen, D1
Feng, S1
Danni, W1
Ning, K1
Jie, LI1
Min, Z1
Shoupei, L1
Chenchen, D1
Zhibin, L1
Qianlei, XU1
Qiang, LI1
Betancor, G1
Bangham, M1
Jeon, JK1
Shah, K1
Lynham, S1
Jimenez-Guardeño, JM1
Malim, MH1
Ding, S1
Grenier, MC1
Tolbert, WD1
Vézina, D1
Sherburn, R1
Richard, J1
Prévost, J1
Chapleau, JP1
Gendron-Lepage, G1
Medjahed, H1
Abrams, C1
Sodroski, J1
Pazgier, M1
Smith, AB1
Finzi, A1
Boban, J2
Thurnher, MM1
Brkic, S2
Lendak, D2
Bugarski Ignjatovic, V1
Todorovic, A1
Kozic, D2
Abdel-Hameed, EA1
Rouster, SD1
Kottilil, S1
Sherman, KE1
Chelala, L1
O'Connor, EE1
Barker, PB2
Zeffiro, TA1
Graham, AS1
Holmes, MJ2
Little, F2
Dobbels, E1
Cotton, MF2
Laughton, B2
van der Kouwe, A1
Meintjes, EM2
Robertson, FC2
Ding, Y1
Lin, H1
Chen, X1
Zhu, B1
Xu, X2
Shen, W1
Gao, M1
He, N1
Rahimy, E1
Li, FY1
Hagberg, L1
Fuchs, D1
Robertson, K1
Meyerhoff, DJ4
Zetterberg, H1
Price, RW1
Gisslén, M1
Spudich, S1
Randall, SR1
van der Kouwe, AJW1
Anabire, NG1
Tetteh, WJ1
Obiri-Yaboah, D1
Annan, I1
Luuse, AT1
Aryee, PA1
Helegbe, GK1
Hagan, OCK1
Eliason, S1
Li, CX1
Zhang, X1
Komery, A1
Li, Y1
Mao, H1
Herndon, JG1
Novembre, FJ1
Winston, A3
Puls, R2
Kerr, SJ2
Duncombe, C2
Li, P1
Gill, JM2
Ramautarsing, R1
Taylor-Robinson, SD2
Emery, S2
Cooper, DA2
Rollet-Kurhajec, KC1
Moodie, EE1
Walmsley, S1
Cooper, C1
Pick, N1
Klein, MB1
Sailasuta, N1
Ananworanich, J1
Lerdlum, S1
Sithinamsuwan, P1
Fletcher, JL1
Tipsuk, S1
Pothisri, M1
Jadwattanakul, T1
Jirajariyavej, S1
Chalermchai, T1
Catella, S1
Busovaca, E1
Desai, A1
Paul, R1
Valcour, V1
Vigneswaran, S1
Rojas, JH1
Garvey, L1
Taylor-Robinson, S1
Van Dalen, YW1
Blokhuis, C1
Cohen, S1
Ter Stege, JA1
Teunissen, CE1
Kuhle, J1
Kootstra, NA1
Scherpbier, HJ1
Kuijpers, TW1
Reiss, P1
Majoie, CBLM1
Caan, MWA1
Pajkrt, D1
Bairwa, D1
Kumar, V1
Vyas, S1
Das, BK1
Srivastava, AK1
Pandey, RM1
Sharma, SK1
Jagannathan, NR1
Sinha, S1
Iqbal, Z1
Wilson, NE1
Keller, MA4
Michalik, DE2
Church, JA2
Nielsen-Saines, K2
Deville, J2
Souza, R1
Brecht, ML1
Thomas, MA3
Turkulov, V1
Ostojic, J1
Semnic, R1
Paul, RH1
Ernst, T2
Brickman, AM1
Yiannoutsos, CT3
Tate, DF1
Cohen, RA1
Navia, BA2
Leal, E1
Silva, WP1
Sucupira, MC1
Janini, LM1
Diaz, RS1
Mohamed, MA1
Lentz, MR2
Lee, V2
Halpern, EF2
Sacktor, N1
Selnes, O1
Pomper, MG1
Li, PC1
Petoumenos, K1
Lin, K1
Taylor, MJ5
Heaton, R1
Franklin, D1
Jernigan, T1
Fennema-Notestine, C1
McCutchan, A1
Atkinson, JH1
Ellis, RJ3
McArthur, J1
Simpson, D1
Collier, AC1
Marra, C1
Gelman, B1
Clifford, D1
Grant, I4
Letendre, SL2
Zheng, JC1
Kaul, M1
Marquie-Beck, J1
Navia, B1
Kim, WK1
Kim, H1
Soulas, C1
Venna, N1
Rosenberg, ES1
Williams, K1
González, RG1
Inácio, V1
Turkman, AA1
Nakas, CT2
Alonzo, TA1
Nagarajan, R1
Sarma, MK1
Chang, L2
Natha, U1
Wright, M1
Hayes, J3
Mason, K1
Critton-Mastandrea, T1
Nazarian, S1
Jing, J1
Bladowska, J1
Zimny, A1
Kołtowska, A1
Szewczyk, P1
Knysz, B1
Gąsiorowski, J1
Furdal, M1
Sąsiadek, MJ1
Zheng, YH1
Yu, HF1
Peterlin, BM1
Vyakarnam, A1
Sidebottom, D1
Murad, S1
Underhill, JA1
Easterbrook, PJ1
Dalgleish, AG1
Peakman, M1
Venkatraman, TN1
Thomas, A1
Deveikis, A2
LoPresti, C1
Berman, N1
Walot, I1
Padilla, S1
Johnston-Jones, J1
Katz-Brull, R1
Lenkinski, RE1
Du Pasquier, RA1
Koralnik, IJ1
Pfefferbaum, A1
Adalsteinsson, E1
Sullivan, EV1
Nelson, JA1
Dou, H1
Ellison, B1
Uberti, M1
Xiong, H1
Anderson, E1
Mellon, M1
Gelbard, HA1
Boska, M1
Gendelman, HE1
Hu, Q1
Napier, KB1
Trent, JO1
Wang, Z1
Taylor, S1
Griffin, GE1
Peiper, SC1
Shattock, RJ1
Schweinsburg, BC3
Alhassoon, OM3
Gonzalez, R1
Brown, GG2
Letendre, S1
Videen, JS2
McCutchan, JA1
Patterson, TL1
Schuff, N1
Mueller, S1
Chao, L1
Sacrey, DT1
Laxer, K1
Weiner, MW3
Gabis, L1
Belman, A1
Huang, W1
Milazzo, M1
Nachman, S1
Gongvatana, A1
Young-Casey, C1
Roc, AC1
Ances, BM1
Chawla, S1
Korczykowski, M1
Wolf, RL1
Kolson, DL1
Detre, JA1
Poptani, H1
Ejilemele, AA1
Nwauche, CA1
Ejele, OA1
Banakar, S1
Watzl, JQ1
Vion-Dury, J1
Confort-Gouny, S1
Nicoli, F1
Dhiver, C1
Gastaut, JA1
Gastaut, JL1
Cozzone, PJ1
Wilkinson, ID2
Paley, M2
Chong, WK2
Sweeney, BJ1
Shepherd, JK1
Kendall, BE2
Hall-Craggs, MA2
Harrison, MJ1
Malley, SD1
Grange, JM1
Hamedi-Sangsari, F1
Vila, JR1
Sweeney, B1
Shepard, JK1
Beecham, M1
Miller, RF1
Weller, IV1
Fein, G2
Simone, IL1
Federico, F1
Tortorella, C1
Andreula, CF1
Zimatore, GB1
Giannini, P1
Angarano, G1
Lucivero, V1
Picciola, P1
Carrara, D1
Bellacosa, A1
Livrea, P1
Bloomer, C1
Cardenas, V1
Norman, D1
Delaugerre, C1
Mouroux, M1
Yvon-Groussin, A1
Simon, A1
Angleraud, F1
Huraux, JM1
Agut, H1
Katlama, C1
Calvez, V1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomised, Open-label, 96-week Study Comparing the Safety and Efficacy of Three Different Combination Antiretroviral Regimens as Initial Therapy for HIV Infection.[NCT00335322]Phase 4329 participants (Actual)Interventional2007-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Time Weighted Mean Change From Baseline Plasma HIV-RNA

(NCT00335322)
Timeframe: 144 weeks

Interventionlog copies/mL (Mean)
TDF/FTC+EFV-2.77
TDF/FTC+ r/ATV-2.88
TDF/FTC + AZT+ABC-2.54

Time-weighted Mean Change From Baseline Plasma HIV-RNA.

(NCT00335322)
Timeframe: 48 weeks

Interventionlog copies/mL (Mean)
TDF/FTC+EFV-2.59
TDF/FTC+r/ATV-2.69
TDF/FTC+AZT+ABC-2.39

Reviews

2 reviews available for aspartic acid and HIV Infections

ArticleYear
Meta-analysis of brain metabolite differences in HIV infection.
    NeuroImage. Clinical, 2020, Volume: 28

    Topics: Aspartic Acid; Brain; Choline; Creatine; HIV Infections; Humans; Inositol; Magnetic Resonance Imagin

2020
N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.
    Advances in experimental medicine and biology, 2006, Volume: 576

    Topics: Aging; Alcoholism; Amyotrophic Lateral Sclerosis; Aspartic Acid; Biomarkers; Brain; Brain Injuries;

2006

Trials

3 trials available for aspartic acid and HIV Infections

ArticleYear
Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.
    PloS one, 2015, Volume: 10, Issue:2

    Topics: Anti-HIV Agents; Aspartic Acid; Brain Chemistry; Cognition; Creatine; Drug Therapy, Combination; HIV

2015
Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Mar-15, Volume: 50, Issue:6

    Topics: AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartic Acid; Brain

2010
Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors.
    Journal of neurovirology, 2005, Volume: 11, Issue:4

    Topics: Adult; Aspartic Acid; Brain; Cell Respiration; Didanosine; Female; HIV Infections; Humans; Lamivudin

2005

Other Studies

50 other studies available for aspartic acid and HIV Infections

ArticleYear
MR spectroscopy and diffusion imaging in people with human immunodeficiency virus: Relationships to clinical and immunologic findings.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2022, Volume: 32, Issue:1

    Topics: Aspartic Acid; Brain; HIV; HIV Infections; Humans; Leukocytes, Mononuclear; Magnetic Resonance Spect

2022
Sterile alpha motif and histidine-aspartic acid domain-containing protein 1 expression and its relationship with T cell activation in human immunodeficiency virus/acquired immune deficiency syndrome patients with lung-spleen deficiency syndrome pattern.
    Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2022, Volume: 42, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Aspartic Acid; Histidine; HIV; HIV Infections; Humans; Lung; SAM

2022
MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
    mBio, 2022, 08-30, Volume: 13, Issue:4

    Topics: Alanine; Animals; Antiviral Agents; Aspartic Acid; Capsid Proteins; DNA, Viral; HIV Infections; HIV-

2022
A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity.
    Journal of virology, 2019, 12-15, Volume: 93, Issue:24

    Topics: Antibodies, Neutralizing; Antibody-Dependent Cell Cytotoxicity; Aspartic Acid; CD4 Antigens; CD4-Pos

2019
Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
    Scientific reports, 2019, 12-24, Volume: 9, Issue:1

    Topics: Adult; Algorithms; Anti-HIV Agents; Aspartic Acid; Brain; Brain Neoplasms; Cell Communication; Cell

2019
The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 08-02, Volume: 73, Issue:3

    Topics: Aspartate Aminotransferases; Aspartic Acid; Biomarkers; Hepacivirus; Hepatitis C; Hepatitis C, Chron

2021
MRS suggests multi-regional inflammation and white matter axonal damage at 11 years following perinatal HIV infection.
    NeuroImage. Clinical, 2020, Volume: 28

    Topics: Anti-Retroviral Agents; Aspartic Acid; Child; Creatine; Female; HIV Infections; Humans; Inflammation

2020
Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection.
    EBioMedicine, 2021, Volume: 71

    Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Atherosclerosis; Cognitive Dysfunction; Female; Glu

2021
Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
    The Journal of infectious diseases, 2017, 04-01, Volume: 215, Issue:7

    Topics: Adult; Antiretroviral Therapy, Highly Active; Aspartic Acid; Biomarkers; Blood-Brain Barrier; Creati

2017
Longitudinal increases of brain metabolite levels in 5-10 year old children.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Aspartic Acid; Brain; Child; Child, Preschool; Creatine; Female; Glutamic Acid; HIV Infections; Huma

2017
Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana.
    BMC research notes, 2019, Jul-31, Volume: 12, Issue:1

    Topics: Adult; Alanine Transaminase; Aspartic Acid; Blood Platelets; Coinfection; Cross-Sectional Studies; F

2019
Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.
    Journal of neurovirology, 2014, Volume: 20, Issue:6

    Topics: Animals; Aspartic Acid; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Choline; Corpus Stri

2014
Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Adult; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Aspartic Acid; Biomarkers

2015
Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
    Journal of acquired immune deficiency syndromes (1999), 2016, Jan-01, Volume: 71, Issue:1

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartic Acid; Biomarkers; Brain; Cho

2016
Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    The neuroradiology journal, 2015, Volume: 28, Issue:6

    Topics: Adult; Antiretroviral Therapy, Highly Active; Aspartic Acid; Basal Ganglia; Brain; Brain Chemistry;

2015
Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.
    Medicine, 2016, Volume: 95, Issue:12

    Topics: Adolescent; AIDS Dementia Complex; Aspartic Acid; Brain; CD4 Lymphocyte Count; Child; Choline; Cogni

2016
Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
    BMC neurology, 2016, Jul-12, Volume: 16

    Topics: Adult; Aspartic Acid; Basal Ganglia; Case-Control Studies; Choline; Creatine; Dipeptides; Female; Fr

2016
Pilot Assessment of Brain Metabolism in Perinatally HIV-Infected Youths Using Accelerated 5D Echo Planar J-Resolved Spectroscopic Imaging.
    PloS one, 2016, Volume: 11, Issue:9

    Topics: Adolescent; AIDS Dementia Complex; Algorithms; Anti-HIV Agents; Aspartic Acid; Brain; Case-Control S

2016
HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients.
    European radiology, 2017, Volume: 27, Issue:10

    Topics: Adult; AIDS Dementia Complex; Aspartic Acid; Biomarkers; Brain; Case-Control Studies; Choline; Creat

2017
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV.
    Journal of the International Neuropsychological Society : JINS, 2008, Volume: 14, Issue:5

    Topics: Adult; Affect; Aspartic Acid; Choline; Cognition Disorders; Creatine; Female; HIV Infections; Humans

2008
Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop.
    Virology, 2008, Nov-25, Volume: 381, Issue:2

    Topics: Amino Acid Sequence; Aspartic Acid; Brazil; Evolution, Molecular; Glutamic Acid; HIV Envelope Protei

2008
Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.
    Radiology, 2010, Volume: 254, Issue:2

    Topics: Adult; AIDS Dementia Complex; Analysis of Variance; Aspartic Acid; Case-Control Studies; Chi-Square

2010
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals.
    Journal of clinical and experimental neuropsychology, 2011, Volume: 33, Issue:3

    Topics: Adult; Aspartic Acid; Brain Injuries; Cognition Disorders; Depression; Executive Function; Female; H

2011
Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.
    Journal of neurovirology, 2011, Volume: 17, Issue:1

    Topics: Adult; Aspartic Acid; CD4 Lymphocyte Count; Cerebrum; Chemokines; Cohort Studies; Creatine; Female;

2011
Alterations in brain metabolism during the first year of HIV infection.
    Journal of neurovirology, 2011, Volume: 17, Issue:3

    Topics: Adult; Anti-Retroviral Agents; Aspartic Acid; Basal Ganglia; Choline; Frontal Lobe; GPI-Linked Prote

2011
Nonparametric Bayesian estimation of the three-way receiver operating characteristic surface.
    Biometrical journal. Biometrische Zeitschrift, 2011, Volume: 53, Issue:6

    Topics: Aspartic Acid; Bayes Theorem; Biometry; Creatinine; HIV Infections; Humans; Nervous System Diseases;

2011
Neuropsychological function and cerebral metabolites in HIV-infected youth.
    Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012, Volume: 7, Issue:4

    Topics: Adolescent; Amino Acids; Aspartic Acid; Brain Chemistry; CD4 Lymphocyte Count; Child; Cognition; Fem

2012
Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    European journal of radiology, 2013, Volume: 82, Issue:4

    Topics: Adult; Analysis of Variance; Anti-HIV Agents; Aspartic Acid; Brain; Case-Control Studies; Choline; C

2013
Human p32 protein relieves a post-transcriptional block to HIV replication in murine cells.
    Nature cell biology, 2003, Volume: 5, Issue:7

    Topics: 3T3 Cells; Amino Acid Sequence; Animals; Aspartic Acid; Carrier Proteins; Gene Products, rev; Glycin

2003
Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection.
    Immunology, 2004, Volume: 112, Issue:1

    Topics: Alleles; Aspartic Acid; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Disease Progression; Femal

2004
Altered neurometabolite development in HIV-infected children: correlation with neuropsychological tests.
    Neurology, 2004, May-25, Volume: 62, Issue:10

    Topics: Adolescent; Age Factors; Aspartic Acid; Brain; Brain Chemistry; CD4 Lymphocyte Count; Child; Choline

2004
Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy.
    Neurology, 2004, Sep-14, Volume: 63, Issue:5

    Topics: Adult; Aspartic Acid; Cerebellum; Cerebral Cortex; Choline; Creatine; Disease Progression; Female; H

2004
Cortical NAA deficits in HIV infection without dementia: influence of alcoholism comorbidity.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:7

    Topics: Adult; Alcoholism; Aspartic Acid; Brain Mapping; Case-Control Studies; Cerebral Cortex; Choline; Com

2005
Coregistration of quantitative proton magnetic resonance spectroscopic imaging with neuropathological and neurophysiological analyses defines the extent of neuronal impairments in murine human immunodeficiency virus type-1 encephalitis.
    Journal of neuroscience research, 2005, May-15, Volume: 80, Issue:4

    Topics: AIDS Dementia Complex; Animals; Aspartic Acid; Brain Mapping; Calcium-Binding Proteins; Capsid Prote

2005
Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Journal of molecular biology, 2005, Jul-22, Volume: 350, Issue:4

    Topics: Amino Acid Sequence; Asparagine; Aspartic Acid; CD4-Positive T-Lymphocytes; Chemokine CCL5; Gene Pro

2005
Clinical and imaging study of human immunodeficiency virus-1-infected youth receiving highly active antiretroviral therapy: pilot study using magnetic resonance spectroscopy.
    Journal of child neurology, 2006, Volume: 21, Issue:6

    Topics: Adolescent; Antiretroviral Therapy, Highly Active; Aspartic Acid; Brain; Child; Choline; Creatine; F

2006
Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy.
    Journal of neurovirology, 2007, Volume: 13, Issue:2

    Topics: Adult; Aspartic Acid; Basal Ganglia; Brain; Brain Diseases; CD4 Lymphocyte Count; Central Nervous Sy

2007
Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
    Archives of neurology, 2007, Volume: 64, Issue:9

    Topics: Adult; AIDS Dementia Complex; Antiretroviral Therapy, Highly Active; Aspartic Acid; Atrophy; Biomark

2007
Pattern of abnormal liver enzymes in HIV patients presenting at a Nigerian Tertiary Hospital.
    The Nigerian postgraduate medical journal, 2007, Volume: 14, Issue:4

    Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartic Acid; Cohort Studies; Female

2007
Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
    NeuroImage, 2008, Mar-01, Volume: 40, Issue:1

    Topics: Adult; Aging; AIDS Dementia Complex; Algorithms; Aspartic Acid; Basal Ganglia; Brain; Brain Chemistr

2008
Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Aspartic Acid; Brain; Child; Choline; Creatine; gamma-Aminobutyric Acid; HIV Infe

2008
Localized brain proton MRS metabolic patterns in HIV-related encephalopathies.
    Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie, 1994, Volume: 317, Issue:9

    Topics: AIDS Dementia Complex; Aspartic Acid; Brain; Choline; Creatine; HIV Infections; Humans; Magnetic Res

1994
Proton spectroscopy in HIV infection: relaxation times of cerebral metabolites.
    Magnetic resonance imaging, 1994, Volume: 12, Issue:6

    Topics: Adult; Aspartic Acid; Brain; CD4 Lymphocyte Count; Choline; Creatine; Female; HIV Infections; HIV Se

1994
Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.
    Proceedings of the National Academy of Sciences of the United States of America, 1994, Nov-08, Volume: 91, Issue:23

    Topics: Antiviral Agents; Asparagine; Aspartic Acid; Cell Survival; Cells, Cultured; Didanosine; Drug Synerg

1994
Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings.
    Radiology, 1993, Volume: 188, Issue:1

    Topics: Adult; Aspartic Acid; Brain; CD4-Positive T-Lymphocytes; Choline; Creatine; Female; HIV Infections;

1993
Deep gray matter structures in HIV infection: a proton MR spectroscopic study.
    AJNR. American journal of neuroradiology, 1996, Volume: 17, Issue:5

    Topics: Adult; AIDS Dementia Complex; Aspartic Acid; Basal Ganglia; Brain; Cerebral Ventricles; Choline; Cor

1996
Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.
    Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 64, Issue:4

    Topics: Adolescent; Adult; AIDS Dementia Complex; Aspartic Acid; Case-Control Studies; Choline; Creatine; Di

1998
Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.
    Neurology, 1999, Mar-23, Volume: 52, Issue:5

    Topics: Adult; Aspartic Acid; Brain Chemistry; Choline; Cognition Disorders; HIV Infections; HIV Seropositiv

1999
MR spectroscopy in HIV and stimulant dependence HNRC Group. HIV Neurobehavioral Research Center.
    Journal of the International Neuropsychological Society : JINS, 2000, Volume: 6, Issue:1

    Topics: Adult; Aspartic Acid; Brain; Caudate Nucleus; Female; Gyrus Cinguli; HIV Infections; Humans; Magneti

2000
Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3

    Topics: Alanine; Amino Acid Substitution; Anti-HIV Agents; Aspartic Acid; Drug Resistance, Microbial; Gene F

2001